MARKETSnap
  • Market Snapshots
    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
    • P/E Ratios
      • Large Caps
      • Absolute
      • Total Market PE
    • Stocks Performance
      • Large Caps
      • Absolute
    • Industries Performance
      • Industry
      • Sector
  • Analyze Stock
    • Analyze a stockAnalyze EMEIS.PA →
    • FindStock Picks / Stock Screener
    • Value · EMEIS.PAIntrinsic Value Calculator
    • Invest · EMEIS.PAInvestment Case
    • Hold · EMEIS.PA5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding
    Calculator
  • Investing Philosophy
  • More
    • Charts
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
EMEI

EMEIS.PA

Emeis

$10.2
0.29
 (2.93%)
Exchange:  PAR
Market Cap:  1.642B
Shares Outstanding:  161.103M
Delayed data
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  HealthcareView sector performance
Industry:  Medical – Care FacilitiesView industry performance
   
CEO:  Laurent Guillot
Full Time Employees:  84600
Address: 
12, rue Jean-JaurEs
Puteaux
IDF
92813
FR
Website:  https://www.emeis.com
Emeis Société anonyme operates as a prominent provider of diverse healthcare services, encompassing the management of nursing homes, assisted-living facilities, specialized post-acute and rehabilitation hospitals, and psychiatric treatment centers. Within its elderly care residences, the company delivers tailored support alongside comprehensive logistical and residential amenities, including comfortable accommodation, meal services, laundry, and room maintenance. These facilities also enrich residents’ lives with a variety of daily events, recreational activities, and therapeutic workshops. Emeis’s post-acute and rehabilitation hospitals are equipped to treat a wide array of medical conditions, such as geriatric issues, musculoskeletal and neurological disorders, cardiovascular and hematological ailments, oncology recovery, and care for individuals in persistent vegetative or minimally conscious states. The psychiatric hospitals address an extensive spectrum of mental health concerns, ranging from mood, anxiety, and obsessive-compulsive disorders to addictions, eating disorders, sleep disturbances, personality disorders, age-related psychiatric conditions, psychosis, and stress-induced conditions like burnout, chronic fatigue syndrome, fibromyalgia, psychosomatic issues, and post-traumatic stress disorder. Furthermore, they offer specialized psychiatric care for geriatrics, children, young adults, and parent-child dynamics, serving both public and private patients. Complementing its institutional offerings, Emeis also provides comprehensive home care solutions. These include practical domestic assistance such as cleaning, meal preparation, ironing, gardening, and running errands; daily living support encompassing day or night supervision and aid with hygiene and meals; and mobility assistance. Founded in 1989 and headquartered in Puteaux, France, the company maintains an expansive international presence, with operations spanning numerous countries across Europe, Latin America, and Asia, including France, Belgium, Spain, Italy, Ireland, Switzerland, Austria, Germany, the Czech Republic, Poland, the Netherlands, Luxembourg, Portugal, Brazil, Russia, Slovenia, Uruguay, Colombia, Mexico, Chile, Latvia, Croatia, and China.

Click to read more…

Revenue Segmentation

🔒 You are currently logged out

Login

It’s free

Industry Peers

TICKERCOMPANYMKT CAPP/EFWD P/EROIC
EMEMEIS.PA logoEMEIS.PAEmeis1.6B——4.0%
AGAGL logoAGLAgilon Health, Inc.1.6B——-90.2%
PNPNTG logoPNTGThe Pennant Group, Inc.1.5B44.331.15.0%
SNSNDA logoSNDASonida Senior Living, Inc.1.8B——-3.6%
HCHCSG logoHCSGHealthcare Services Group, Inc.1.8B16.220.014.3%
AMAMN logoAMNAMN Healthcare Services, Inc.1.8B17.414.26.4%

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

No earnings call materials on file for this symbol yet.

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue5,197,7595,635,8005,895,389
Gross Profit655,9284,509,3804,761,109
EBITDA2,802,601497,094425,704
Operating Income-918,729-38,199173,250
Net Income1,354,899-412,065-298,398

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets13,908,00013,408,58512,653,671
Total Liabilities12,019,57211,686,66011,245,046
Total Stockholders Equity1,886,5581,724,8941,407,803
Total Debt9,160,9958,858,4198,604,986
Cash and Cash Equivalents644,954518,716337,092

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow366,145472,053680,319
Capital Expenditure-149,248-143,439-165,906
Free Cash Flow216,897328,614514,413
Net Income1,354,899-415,457-298,898
Net Change in Cash-211,463-126,238-181,624

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Low)6,792,610.120Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (High)7,071,071.731Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Avg)6,944,600Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Low)1,169,861.113Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (High)1,192,458.260Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Avg)1,182,194.712Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Low)375,648.220Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (High)395,802.266Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Avg)386,648.366Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Low)0Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (High)0Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Avg)0Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Avg)2.400Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (High)2.460Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Low)2.330Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated Revenue)2Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated EPS)1Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
  ?P/S
 (TTM)
: 
0.22
?Net Income
 (TTM)
: 
  ?P/E
 (TTM)
: 
-6.08
?Enterprise Value
 (TTM)
: 
9.288B  ?EV/FCF
 (TTM)
: 
16.14
?Dividend Yield
 (TTM)
: 
0%  ?Payout Ratio
 (TTM)
: 
-3.71%
?ROE
 (TTM)
: 
-15.35%  ?ROIC
 (TTM)
: 
4.02%
?Net Debt
 (TTM)
: 
  ?Debt/Equity
 (TTM)
: 
3.8
?P/B
 (TTM)
: 
0.76  ?Current Ratio
 (TTM)
: 
0.83

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Research Access for high/low estimates and the interactive table.

Forward P/E 1YResearch AccessResearch AccessResearch AccessResearch Access
N/AResearch AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MarketSnap estimates EMEIS.PA intrinsic value between $16.65 – $25.32 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate EMEIS Intrinsic Value

Common questions about EMEIS.PA valuation

Is Emeis (EMEIS.PA) overvalued or undervalued right now?

MarketSnap estimates intrinsic value for Emeis (EMEIS.PA) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is EMEIS.PA a buy, hold, or sell for long-term investors?

MarketSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether EMEIS.PA trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is EMEIS.PA’s P/E ratio?

You can see EMEIS.PA’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for EMEIS.PA?

MarketSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MarketSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is EMEIS.PA a good long-term investment?

Whether EMEIS.PA fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MarketSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

Research tools for Emeis

  • Emeis intrinsic value calculatorEstimate what the business is worth
  • Emeis 5-year outlookWhat has to go right, and what could go wrong
EMEIS.PA

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

2.93
MarketSnap

Trading Metrics:

Open: 9.97   Previous Close: 9.91
Day Low: 9.96   Day High: 10.25
Year Low: 9.34   Year High: 16
Price Avg 50: 11.23   Price Avg 200: 13.45
Volume: 127743   Average Volume: 198775

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
      • Large Caps
      • Absolute
      • Total Market PE
      • Large Caps
      • Absolute
      • Industry
      • Sector
    • Analyze a stockAnalyze EMEIS.PA →
    • FindStock Picks / Stock Screener
    • Value · EMEIS.PAIntrinsic Value Calculator
    • Invest · EMEIS.PAInvestment Case
    • Hold · EMEIS.PA5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding Calculator
    • Charts
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Investing Philosophy
  • Nexus
    • Recent Activity
      • Overview
      • My Valuations
      • My Investment Journal
      • Watchlists & Portfolio
    • Settings
    • Public profile ↗
  • Log in

Media

Watch Listen Read